<DOC>
	<DOCNO>NCT02381470</DOCNO>
	<brief_summary>Faropenem oral penem , closely related carbapenem class use treatment bacterial infection . It vitro activity Mycobacterium tuberculosis trial aim determine activity faropenem amoxicillin/clavulanic acid patient pulmonary TB .</brief_summary>
	<brief_title>Early Bactericidal Activity Study Faropenem ( With Amoxicillin/Clavulanic Acid ) Patients With Pulmonary Tuberculosis</brief_title>
	<detailed_description>This Phase II randomise , control , open-label , early bactericidal activity trial 28 patient age 18 70 newly-diagnosed smear positive pulmonary TB , yet start standard TB therapy recruit . Patients randomise one 3 arm - Arm A : Faropenem 400mg amoxicillin/clavulanic acid ( 500mg/125mg ) , three time daily 5 day ( n=12 ) Arm B : Pyrazinamide 2g ( 1.5g weight &lt; 50kg ) daily 5 day ( n=8 ) Arm C : Isoniazid 300mg daily 5 day ( n=8 ) Following 5 day study medication study end patient change standard combination TB therapy enter normal clinical follow-up . In addition CFU TTP relate primary secondary outcome measure , outcome measure pharmacokinetics faropenem , change RPF-dependent colony count , change expression select signature Mtb gene sputum transcriptome , change host transcriptome change host immune profile determine .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Pyrazinamide</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>1 . Aged 18 70 year 2 . Clinical feature compatible pulmonary TB 3 . Sputum smear grade least 1 + 4 . Estimated produce least 5ml sputum per day 5 . Willing comply study procedure able provide write informed consent . 1 . Suspected miliary TB TB meningitis 2 . Patients receive TB treatment within previous 6 month 3 . Patients ill tolerate 5day delay standard therapy 4 . Concurrent bacterial pneumonia 5 . Known hypersensitivity betalactam drug ( penicillin , carbapanems ) study drug ( isoniazid , pyrazinamide ) 6 . Estimated creatinine clearance &lt; 80 ml/min screen blood test , calculate use CockcroftGault formula 7 . ALT &gt; 2.5 time upper limit normal screen blood test . 8 . Women currently pregnant breastfeed . 9 . Any significant condition would , opinion investigator , compromise patient 's safety outcome trial . 10 . Participation clinical intervention trial research protocol ( participation study involve intervention may allow , must discuss approved Chief Investigator )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>